These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 28235409)

  • 61. HDAC gene expression in pancreatic tumor cell lines following treatment with the HDAC inhibitors panobinostat (LBH589) and trichostatine (TSA).
    Mehdi O; Françoise S; Sofia CL; Urs G; Kevin Z; Bernard S; Igor S; Anabela CD; Dominique L; Eric M; Ali O
    Pancreatology; 2012; 12(2):146-55. PubMed ID: 22487525
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Antineoplastic effects of rosiglitazone and PPARgamma transactivation in neuroblastoma cells.
    Cellai I; Benvenuti S; Luciani P; Galli A; Ceni E; Simi L; Baglioni S; Muratori M; Ottanelli B; Serio M; Thiele CJ; Peri A
    Br J Cancer; 2006 Oct; 95(7):879-88. PubMed ID: 16969347
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Investigation of anticancer mechanism of oleuropein via cell cycle and apoptotic pathways in SH-SY5Y neuroblastoma cells.
    Seçme M; Eroğlu C; Dodurga Y; Bağcı G
    Gene; 2016 Jul; 585(1):93-99. PubMed ID: 27032461
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The Olive Leaves Extract Has Anti-Tumor Effects against Neuroblastoma through Inhibition of Cell Proliferation and Induction of Apoptosis.
    Morandi F; Bensa V; Calarco E; Pastorino F; Perri P; Corrias MV; Ponzoni M; Brignole C
    Nutrients; 2021 Jun; 13(7):. PubMed ID: 34202787
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Differential effect of long-term drug selection with doxorubicin and vorinostat on neuroblastoma cells with cancer stem cell characteristics.
    Zheng X; Naiditch J; Czurylo M; Jie C; Lautz T; Clark S; Jafari N; Qiu Y; Chu F; Madonna MB
    Cell Death Dis; 2013 Jul; 4(7):e740. PubMed ID: 23887631
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Combination of retinoid and histone deacetylase inhibitor produced an anti-tumor effect in cutaneous T-cell lymphoma by restoring tumor suppressor gene, retinoic acid receptorβ2, via histone acetylation.
    Kato Y; Egusa C; Maeda T; Tsuboi R
    J Dermatol Sci; 2016 Jan; 81(1):17-25. PubMed ID: 26596218
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Second-generation proteasome inhibitor carfilzomib sensitizes neuroblastoma cells to doxorubicin-induced apoptosis.
    Guan S; Zhao Y; Lu J; Yu Y; Sun W; Mao X; Chen Z; Xu X; Pan J; Sun S; Yang J
    Oncotarget; 2016 Nov; 7(46):75914-75925. PubMed ID: 27713150
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Pre-clinical characterization of 4SC-202, a novel class I HDAC inhibitor, against colorectal cancer cells.
    Zhijun H; Shusheng W; Han M; Jianping L; Li-Sen Q; Dechun L
    Tumour Biol; 2016 Aug; 37(8):10257-67. PubMed ID: 26831668
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Smoothened-independent activation of hedgehog signaling by rearranged during transfection promotes neuroblastoma cell proliferation and tumor growth.
    Ruan H; Luo H; Wang J; Ji X; Zhang Z; Wu J; Zhang X; Wu X
    Biochim Biophys Acta; 2016 Sep; 1860(9):1961-72. PubMed ID: 27316313
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A Small Molecule Strategy for Targeting Cancer Stem Cells in Hypoxic Microenvironments and Preventing Tumorigenesis.
    Kim JH; Verwilst P; Won M; Lee J; Sessler JL; Han J; Kim JS
    J Am Chem Soc; 2021 Sep; 143(35):14115-14124. PubMed ID: 34374290
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Dual Effect of Doxazosin: Anticancer Activity on SH-SY5Y Neuroblastoma Cells and Neuroprotection on an In Vitro Model of Alzheimer's Disease.
    Coelho BP; Gaelzer MM; Dos Santos Petry F; Hoppe JB; Trindade VMT; Salbego CG; Guma FTCR
    Neuroscience; 2019 Apr; 404():314-325. PubMed ID: 30771511
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Combined Treatments with a Retinoid Receptor Agonist and Epigenetic Modulators in Human Neuroblastoma Cells.
    Almeida VR; Vieira IA; Buendia M; Brunetto AT; Gregianin LJ; Brunetto AL; Klamt F; de Farias CB; Abujamra AL; Lopez PLDC; Roesler R
    Mol Neurobiol; 2017 Dec; 54(10):7610-7619. PubMed ID: 27832522
    [TBL] [Abstract][Full Text] [Related]  

  • 73. p53 oligomerization status as an indicator of sensitivity of p53-wildtype neuroblastomas to the combination of DNA damaging agent and Chk1 inhibitor.
    Levesque AA; Pappalardo RM; Puli P; Enzor LA; Angeles C
    PLoS One; 2022; 17(2):e0263463. PubMed ID: 35143532
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Screening a panel of drugs with diverse mechanisms of action yields potential therapeutic agents against neuroblastoma.
    Gheeya JS; Chen QR; Benjamin CD; Cheuk AT; Tsang P; Chung JY; Metaferia BB; Badgett TC; Johansson P; Wei JS; Hewitt SM; Khan J
    Cancer Biol Ther; 2009 Dec; 8(24):2386-95. PubMed ID: 19946221
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Knockdown of galectin-1 facilitated cisplatin sensitivity by inhibiting autophagy in neuroblastoma cells.
    Gao J; Wang W
    Chem Biol Interact; 2019 Jan; 297():50-56. PubMed ID: 30365942
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A High-Content Screening of Anticancer Compounds Suggests the Multiple Tyrosine Kinase Inhibitor Ponatinib for Repurposing in Neuroblastoma Therapy.
    Sidarovich V; De Mariano M; Aveic S; Pancher M; Adami V; Gatto P; Pizzini S; Pasini L; Croce M; Parodi F; Cimmino F; Avitabile M; Emionite L; Cilli M; Ferrini S; Pagano A; Capasso M; Quattrone A; Tonini GP; Longo L
    Mol Cancer Ther; 2018 Jul; 17(7):1405-1415. PubMed ID: 29695637
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Combined effects of curcumin and doxorubicin on cell death and cell migration of SH-SY5Y human neuroblastoma cells.
    Namkaew J; Jaroonwitchawan T; Rujanapun N; Saelee J; Noisa P
    In Vitro Cell Dev Biol Anim; 2018 Oct; 54(9):629-639. PubMed ID: 30136034
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Licochalcone E inhibits trxR1 expression, alters Nrf2/STAT6 signal, and induces antitumor effects in vitro against human SH-SY5Y and SK-N-BE(2) neuroblastoma cells.
    Zhang Q; Zhang J; Liu B; Wei J
    Environ Toxicol; 2022 May; 37(5):1173-1184. PubMed ID: 35092341
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The novel anti-neuroblastoma agent PF403, inhibits proliferation and invasion in vitro and in brain xenografts.
    Li C; Li Y; Lv H; Li S; Tang K; Zhou W; Yu S; Chen X
    Int J Oncol; 2015 Jul; 47(1):179-87. PubMed ID: 25936609
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The dual HDAC and PI3K inhibitor, CUDC‑907, inhibits tumor growth and stem‑like properties by suppressing PTX3 in neuroblastoma.
    Li M; Hu Y; Wang J; Xu Y; Hong Y; Zhang L; Luo Q; Zhen Z; Lu S; Huang J; Zhu J; Zhang Y; Que Y; Sun F
    Int J Oncol; 2024 Feb; 64(2):. PubMed ID: 38063204
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.